(0.06%) 5 472.43 points
(0.06%) 39 135 points
(0.38%) 17 786 points
(-0.05%) $80.79
(-3.66%) $2.66
(-0.77%) $2 312.90
(0.21%) $28.93
(3.61%) $1 022.00
(0.29%) $0.936
(0.71%) $10.68
(0.45%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases...
Stats | |
---|---|
今日成交量 | 960 928 |
平均成交量 | 0 |
市值 | 0.00 |
EPS | $0.0766 ( Q2 | 2022-08-15 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
47.62 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.137 (2.20%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-08-22 | Rosen Robert | Sell | 30 000 | Stock Option (Right to Buy) |
2022-08-22 | Rosen Robert | Sell | 18 000 | Stock Option (Right to Buy) |
2022-08-22 | Rosen Robert | Sell | 10 000 | Stock Option (Right to Buy) |
2022-08-22 | Rosen Robert | Sell | 10 000 | Stock Option (Right to Buy) |
2022-08-22 | Rosen Robert | Sell | 10 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-100.00 |
Last 100 transactions |
Buy: 0 | Sell: 11 680 911 |
音量 相关性
La Jolla Pharmaceutical 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
La Jolla Pharmaceutical 相关性 - 货币/商品
La Jolla Pharmaceutical 财务报表
Annual | 2021 |
营收: | $75.72M |
毛利润: | $62.23M (82.19 %) |
EPS: | $0.720 |
FY | 2021 |
营收: | $75.72M |
毛利润: | $62.23M (82.19 %) |
EPS: | $0.720 |
FY | 2020 |
营收: | $33.42M |
毛利润: | $25.60M (76.60 %) |
EPS: | $-1.440 |
FY | 2019 |
营收: | $23.05M |
毛利润: | $20.66M (89.62 %) |
EPS: | $-4.30 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
La Jolla Pharmaceutical
La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The company has license agreement with Everest Medicines Limited to develop and commercialize XERAVA; and PAION AG to commercialize GIAPREZA and XERAVA. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts. As of August 22, 2022, La Jolla Pharmaceutical Company operates as a subsidiary of Innoviva, Inc.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。